Vaccinia virus tropism for primary hematolymphoid cells is determined by restricted expression of a unique virus receptor

被引:63
作者
Chahroudi, A
Chavan, R
Koyzr, N
Waller, EK
Silvestri, G
Feinberg, MB
机构
[1] Emory Univ, Emory Vaccine Ctr, Sch Med, Atlanta, GA 30329 USA
[2] Emory Univ, Winship Canc Inst, Sch Med, Atlanta, GA 30329 USA
关键词
D O I
10.1128/JVI.79.16.10397-10407.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The presumed broad tropism of poxviruses has stymied attempts to identify both the cellular receptor(s) and the viral determinant(s) for binding. Detailed studies of poxvirus binding to and infection of primary human cells have not been conducted. In particular, the determinants of target cell infection and the consequences of infection for cells involved in the generation of antiviral immune responses are incompletely understood. In this report, we show that vaccinia virus (W) exhibits a more restricted tropism for primary hematolymphoid human cells than has been previously recognized. We demonstrate that vaccinia virus preferentially infects antigen-presenting cells (dendritic cells, monocytes/macrophages, and B cells) and activated T cells, but not resting T cells. The infection of activated T cells is permissive, with active viral replication and production of infectious progeny. Susceptibility to infection is determined by restricted expression of a cellular receptor that is induced de novo upon T-cell activation and can be removed from the cell surface by either trypsin or pronase treatment. The W receptor expressed on activated T cells displays unique characteristics that distinguish it from the receptor used to infect cell lines in culture. The observed restricted tropism of W may have significant consequences for the understanding of natural poxvirus infection and immunity and for poxvirus-based vaccine development.
引用
收藏
页码:10397 / 10407
页数:11
相关论文
共 58 条
[1]   Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine [J].
Amara, RR ;
Villinger, F ;
Altman, JD ;
Lydy, SL ;
O'Neil, SP ;
Staprans, SI ;
Montefiori, DC ;
Xu, Y ;
Herndon, JG ;
Wyatt, LS ;
Candido, MA ;
Kozyr, NL ;
Earl, PL ;
Smith, JM ;
Ma, HL ;
Grimm, BD ;
Hulsey, ML ;
Miller, J ;
McClure, HM ;
McNicholl, JM ;
Moss, B ;
Robinson, HL .
SCIENCE, 2001, 292 (5514) :69-74
[2]   ANTIGENIC DIFFERENCE BETWEEN INTRACELLULAR AND EXTRACELLULAR RABBITPOX VIRUS [J].
APPLEYARD, G ;
HAPEL, AJ ;
BOULTER, EA .
JOURNAL OF GENERAL VIROLOGY, 1971, 13 (OCT) :9-+
[3]   Vaccinia virus-induced apoptosis in immature B lymphocytes:: role of cellular Bcl-2 [J].
Baixeras, E ;
Cebrián, A ;
Albar, J ;
Salas, J ;
Martínez, C ;
Viñuela, E ;
Revilla, Y .
VIRUS RESEARCH, 1998, 58 (1-2) :107-113
[4]  
BENDA R, 1975, J HYG EPID MICROB IM, V19, P93
[5]   Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice [J].
Björck, P .
BLOOD, 2001, 98 (13) :3520-3526
[6]   ROLE OF CELL-ASSOCIATED ENVELOPED VACCINIA VIRUS IN CELL-TO-CELL SPREAD [J].
BLASCO, R ;
MOSS, B .
JOURNAL OF VIROLOGY, 1992, 66 (07) :4170-4179
[7]   Current concepts - Diagnosis and management of smallpox [J].
Breman, JG ;
Henderson, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (17) :1300-1308
[8]   EXPRESSION OF FOREIGN GENES IN CULTURED HUMAN PRIMARY MACROPHAGES USING RECOMBINANT VACCINIA VIRUS VECTORS [J].
BRODER, CC ;
KENNEDY, PE ;
MICHAELS, F ;
BERGER, EA .
GENE, 1994, 142 (02) :167-174
[9]   MOLECULAR CHARACTERIZATION OF THE VACCINIA VIRUS HEMAGGLUTININ GENE [J].
BROWN, CK ;
TURNER, PC ;
MOYER, RW .
JOURNAL OF VIROLOGY, 1991, 65 (07) :3598-3606
[10]   Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: Propagation and generation of recombinant viruses in a nonhuman mammalian cell line [J].
Carroll, MW ;
Moss, B .
VIROLOGY, 1997, 238 (02) :198-211